Tag Archives: The Pancreatic Cancer Action Network

San Diego, CA-based Trovagene Inc. a developer of circulating tumor DNA (ctDNA) molecular diagnostics, announced today that it has been selected by the Pancreatic Cancer Action Network as the liquid biopsy provider to participate in Precision Promise, the first large-scale ...

Read More »